Sign in

    Asana Inc (ASAN)

    Updated Jun 4, 2025, 1:32 AM UTC
    Income Statement - MetricQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025Q1 2026
    Revenues (USD, thousands)171,135.00172,448179,212.00183,882.00188,334723,876187,267
    Cost of Revenues (USD, thousands)17,392.0064,52417,80419,987.0019,798.0019,60477,19319,227
    Gross Profit (USD, thousands)153,743.00587,980154,644159,225.00164,084.00168,730646,683168,040
    Research and Development Expenses (USD, thousands)82,973.00324,68882,79183,286.0084,239341,46775,127
    Sales and Marketing Expenses (USD, thousands)103,921.00391,955104,332108,649.00104,708.00102,261419,95099,841
    General and Administrative Expenses (USD, thousands)34,797.00141,33433,69036,222.0036,270.0045,819152,00136,976
    Total Operating Expenses (USD, thousands)221,691.00857,977220,813236,022.00224,264.00232,319913,418211,944
    Loss from Operations (USD, thousands)(67,948.00)(269,997)(66,169)(60,180.00)(63,589)(266,735)(43,904)
    Interest Income and Other Income (Expense), Net (USD, thousands)20,6244,3606,760.004,949.003,57819,6475,830
    Interest Expense (USD, thousands)(1,005.00)(3,952)(942)(955.00)(934.00)(852)(3,683)(791)
    Loss Before Provision for Income Taxes (USD, thousands)(61,639.00)(253,325)(62,751)(70,992.00)(56,165.00)(60,863)(250,771)(38,865)
    Provision for Income Taxes (USD, thousands)759.003,7059711,197.001,161.001,4364,7651,153
    Net Loss (USD, thousands)(62,398.00)(63,722)(72,189.00)(57,326.00)(62,299)(255,536)(40,018)
    Balance Sheet - MetricQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025Q1 2026
    Cash and cash equivalents (USD, thousands)236,663222,049219,400196,772184,728184,728193,791
    Marketable securities (USD, thousands)282,801282,801302,240302,224258,541282,156282,156277,011
    Restricted cash (USD, thousands)---455316136136289,136
    Accounts receivable, net (USD, thousands)88,32788,32799,77365,06666,89287,56787,56768,076
    Prepaid expenses and other current assets (USD, thousands)51,92551,92550,00453,19448,83746,15446,15449,329
    Total current assets (USD, thousands)659,716659,716674,066640,339571,358600,741600,741588,496
    Property and equipment, net (USD, thousands)96,54396,54396,95595,74296,62795,83695,83694,740
    Operating lease right-of-use assets (USD, thousands)181,731181,731182,296182,261177,626166,545166,545164,810
    Other assets (USD, thousands)23,97023,97024,85127,03428,54528,29328,29329,087
    Total assets (USD, thousands)961,960961,960978,168945,376891,415891,415877,133
    Accounts payable (USD, thousands)6,9076,90712,89513,83412,6069,9229,9227,942
    Accrued expenses and other current liabilities (USD, thousands)75,82175,82168,11172,59869,30783,03183,03178,310
    Deferred revenue, current (USD, thousands)265,306265,306292,191285,508279,560300,798300,798288,993
    Operating lease liabilities, current (USD, thousands)19,17919,17920,31621,20021,55622,06622,06624,118
    Total current liabilities (USD, thousands)367,213367,213393,513393,140383,029415,817415,817399,363
    Term loan, net (USD, thousands)43,61843,61842,38041,14239,29139,29138,053
    Deferred revenue, noncurrent (USD, thousands)5,9165,9164,8823,6842,5812,0052,0051,298
    Operating lease liabilities, noncurrent (USD, thousands)215,084215,084214,108212,855207,527201,733201,733197,082
    Other liabilities (USD, thousands)3,7333,7333,3882,6381,8455,0465,0465,033
    Total liabilities (USD, thousands)635,564635,564658,271653,459634,886663,892663,892640,829
    Common stock (USD, thousands)22222222
    Additional paid-in capital (USD, thousands)1,821,2161,821,2161,880,6751,942,9112,002,7642,059,8482,059,8482,118,447
    Accumulated other comprehensive loss (USD, thousands)(236)(236)(2,472)(778)(983)(3,851)(3,851)1,955
    Accumulated deficit (USD, thousands)(1,494,586)(1,494,586)(1,558,308)(1,650,218)(1,762,513)(1,828,476)(1,828,476)(1,884,100)
    Total stockholders’ equity (USD, thousands)326,396326,396319,897291,917239,270227,523227,523236,304
    Total liabilities and stockholders’ equity (USD, thousands)961,960961,960978,168945,376874,156891,415891,415877,133
    Cash Flow - MetricQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025Q1 2026
    Net loss (USD, thousands)(62,398.00)(257,030)(63,722)(72,189.00)(57,326.00)(62,299.00)(255,536)(40,018)
    Net cash used in operating activities (USD, thousands)(15,337.00)(17,931)(1,898)---14,9256,764
    Net cash provided by (used in) investing activities (USD, thousands)------(6,129)4,176
    Net cash provided by (used in) financing activities (USD, thousands)----(48,919.00)-(58,093)(5,523)
    Depreciation and amortization (USD, thousands)3,937.0014,3444,0144,279.004,437.004,813.0017,5434,963
    Amortization of deferred contract acquisition costs (USD, thousands)6,001.0021,9726,0876,406.006,696.006,718.0025,9076,691
    Stock-based compensation expense (USD, thousands)51,849.00202,41848,64060,107.0051,955.0050,569.00211,27148,167
    Net accretion of discount on marketable securities (USD, thousands)-(3,391)(1,831)(1,725.00)(1,090.00)(864.00)(5,510)(736)
    Non-cash lease expense (USD, thousands)4,092.0018,0904,4524,436.004,640.004,439.0017,9674,540
    Amortization of discount on revolving credit facility and term loan issuance costs (USD, thousands)31.001223031.0030.0031.0012230
    Purchases of marketable securities (USD, thousands)(34,821.00)(319,133)(70,484)(36,642.00)(59,502.00)(67,820.00)(234,448)(34,055)
    Maturities of marketable securities (USD, thousands)17,500.0043,14151,50039,796.00104,309.0044,996.00240,60141,000
    Purchases of property and equipment (USD, thousands)(500.00)(7,721)(1,002)(1,690.00)(1,372.00)(1,505.00)(5,569)(638)
    Capitalized internal-use software costs (USD, thousands)(1,115.00)(5,440)(1,375)(1,408.00)(1,919.00)(2,011.00)(6,713)(2,131)
    Repurchases of common stock (USD, thousands)----(54,847.00)-(78,354)(14,526)
    Proceeds from exercise of stock options (USD, thousands)987.004,8431,0851,044.001,755.005,217.009,1011,257
    Proceeds from employee stock purchase plan (USD, thousands)0.0015,0698,8660.004,799.000.0013,6657,746
    Taxes paid related to net share settlement of equity awards (USD, thousands)(3.00)(10)(4)0.00(1.00)0.00(5)-
    Effect of foreign exchange rates on cash, cash equivalents, and restricted cash (USD, thousands)2,257.00389(1,302)1,120.00(474.00)(1,846.00)(2,502)3,799
    Net decrease in cash, cash equivalents, and restricted cash (USD, thousands)(31,651.00)(289,900)(14,614)(2,194.00)(22,767.00)(12,224.00)(51,799)9,216
    Beginning of period cash, cash equivalents, and restricted cash (USD, thousands)---236,663236,663236,663236,663184,864
    End of period cash, cash equivalents, and restricted cash (USD, thousands)---219,855197,088184,864184,864194,080
    Allowance for expected credit losses (USD, thousands)3,1403,1401993721,0253,1903,1901,027
    Revenue by Geography - Metric [Unit]Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025Q2 2025Q3 2025Q4 2025FY 2025Q1 2026
    U.S. Revenue [$ Million]--------
    International Revenue [$ Million]--------
    Total Revenue [$ Million]--------
    U.S. Revenue Growth [% YoY]---9%----
    International Revenue Growth [% YoY]--14.5%12.3%----